A clinical-stage biotechnology company developing next-generation injectable and oral therapies for obesity and cardiometabolic disease, with a pipeline anchored in GLP-1-based combinations and small-molecule approaches.
A clinical-stage biotechnology company developing next-generation injectable and oral therapies for obesity and cardiometabolic disease, with a pipeline anchored in GLP-1-based combinations and small-molecule approaches.
